• Latest Posts

Lilly to develop Confo pain drug

Antiverse identifies therapeutic antibodies targeting GPCRs

Beyond Biotech podcast 34: eClinical Solutions, GPCR Therapeutics, Orbsen Therapeutics

Maxion Therapeutics raises $16M to target GPCRs

Orbit Discovery and Endevica Bio to develop cachexia therapeutics


GPCR Therapeutics launches multiple myeloma trial

Sosei Heptares signs R&D agreements on gastrointestinal and immune disorders

More News! 9 Nov 2022

PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way

OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

British Biotech Founder Receives the Nobel Prize in Chemistry 2017